Rank | Gene Set | Z-score |
---|---|---|
1 | eosinophil migration (GO:0072677) | 9.94477262 |
2 | cellular response to ethanol (GO:0071361) | 7.34552101 |
3 | immunoglobulin mediated immune response (GO:0016064) | 5.31685488 |
4 | neutrophil activation involved in immune response (GO:0002283) | 5.30650379 |
5 | regulation of mononuclear cell migration (GO:0071675) | 5.27817881 |
6 | regulation of macrophage chemotaxis (GO:0010758) | 4.90536464 |
7 | T cell migration (GO:0072678) | 4.85790864 |
8 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.79307385 |
9 | cellular extravasation (GO:0045123) | 4.70948295 |
10 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 4.56764502 |
11 | positive regulation of mast cell activation (GO:0033005) | 4.55526586 |
12 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.49217038 |
13 | response to peptidoglycan (GO:0032494) | 4.34469039 |
14 | positive regulation of type 2 immune response (GO:0002830) | 4.32967420 |
15 | negative regulation of interleukin-12 production (GO:0032695) | 4.32747085 |
16 | modulation by symbiont of host immune response (GO:0052553) | 4.31329279 |
17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.31329279 |
18 | modulation by symbiont of host defense response (GO:0052031) | 4.31329279 |
19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.31329279 |
20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.31329279 |
21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.31329279 |
22 | detection of molecule of bacterial origin (GO:0032490) | 4.31188234 |
23 | macrophage activation involved in immune response (GO:0002281) | 4.24053182 |
24 | phagocytosis, recognition (GO:0006910) | 4.13059811 |
25 | B cell mediated immunity (GO:0019724) | 4.11188659 |
26 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.04427223 |
27 | positive regulation of mast cell degranulation (GO:0043306) | 4.04427223 |
28 | microglial cell activation (GO:0001774) | 4.02744484 |
29 | lymphocyte chemotaxis (GO:0048247) | 3.93047714 |
30 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.87566150 |
31 | granulocyte chemotaxis (GO:0071621) | 3.84980220 |
32 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.81638336 |
33 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.79352330 |
34 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.73588975 |
35 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.73206170 |
36 | granulocyte migration (GO:0097530) | 3.69675290 |
37 | regulation of T cell tolerance induction (GO:0002664) | 3.69268813 |
38 | regulation of hypersensitivity (GO:0002883) | 3.64883446 |
39 | detection of other organism (GO:0098543) | 3.64133424 |
40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.63540871 |
41 | detection of external biotic stimulus (GO:0098581) | 3.60349982 |
42 | monocyte chemotaxis (GO:0002548) | 3.57843162 |
43 | regulation of tolerance induction (GO:0002643) | 3.55698082 |
44 | positive regulation of lymphocyte migration (GO:2000403) | 3.52160389 |
45 | regulation of mast cell activation (GO:0033003) | 3.50999198 |
46 | defense response to protozoan (GO:0042832) | 3.49948936 |
47 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.49018384 |
48 | regulation of mast cell degranulation (GO:0043304) | 3.43858912 |
49 | response to host immune response (GO:0052572) | 3.42986274 |
50 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.42986274 |
51 | phagocytosis, engulfment (GO:0006911) | 3.42535336 |
52 | macrophage activation (GO:0042116) | 3.39238077 |
53 | platelet dense granule organization (GO:0060155) | 3.39181796 |
54 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.36460706 |
55 | detection of bacterium (GO:0016045) | 3.34971020 |
56 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.34920115 |
57 | neutrophil activation (GO:0042119) | 3.34855288 |
58 | myeloid cell activation involved in immune response (GO:0002275) | 3.32727029 |
59 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.29584436 |
60 | regulation of lymphocyte migration (GO:2000401) | 3.23728102 |
61 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.20719415 |
62 | type I interferon signaling pathway (GO:0060337) | 3.18911926 |
63 | cellular response to type I interferon (GO:0071357) | 3.18911926 |
64 | response to type I interferon (GO:0034340) | 3.16497176 |
65 | detection of biotic stimulus (GO:0009595) | 3.13726080 |
66 | cell wall macromolecule catabolic process (GO:0016998) | 3.12021578 |
67 | positive regulation of macrophage cytokine production (GO:0060907) | 3.10435602 |
68 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08502700 |
69 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.07107093 |
70 | positive regulation of interferon-beta production (GO:0032728) | 3.06882599 |
71 | negative regulation of cell killing (GO:0031342) | 3.04438298 |
72 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.04438298 |
73 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.02038291 |
74 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.01529484 |
75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.00929370 |
76 | positive regulation of interferon-alpha production (GO:0032727) | 2.99071445 |
77 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.97741954 |
78 | positive thymic T cell selection (GO:0045059) | 2.96861105 |
79 | cellular response to interferon-gamma (GO:0071346) | 2.96508118 |
80 | myeloid leukocyte mediated immunity (GO:0002444) | 2.94998546 |
81 | granulocyte activation (GO:0036230) | 2.94976725 |
82 | response to protozoan (GO:0001562) | 2.93586821 |
83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.92497944 |
84 | response to host (GO:0075136) | 2.92497944 |
85 | response to host defenses (GO:0052200) | 2.92497944 |
86 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.91879436 |
87 | T-helper 1 type immune response (GO:0042088) | 2.91655049 |
88 | regulation of interferon-alpha production (GO:0032647) | 2.90358366 |
89 | mast cell activation (GO:0045576) | 2.88658752 |
90 | response to interferon-gamma (GO:0034341) | 2.85561889 |
91 | membrane invagination (GO:0010324) | 2.85276810 |
92 | T cell proliferation (GO:0042098) | 2.84498492 |
93 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.81818009 |
94 | positive regulation of B cell mediated immunity (GO:0002714) | 2.81818009 |
95 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.81728696 |
96 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.81434907 |
97 | regulation of macrophage cytokine production (GO:0010935) | 2.79352114 |
98 | regulation of gamma-delta T cell activation (GO:0046643) | 2.78497421 |
99 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.76876430 |
100 | eosinophil chemotaxis (GO:0048245) | 11.0575960 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.28650606 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.67295352 |
3 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.63754148 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.39375164 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.29471446 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.23826396 |
7 | GATA1_22025678_ChIP-Seq_K562_Human | 3.07766981 |
8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.97749716 |
9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.84631281 |
10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.72632992 |
11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.69613081 |
12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.60851302 |
13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.48392713 |
14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.46736041 |
15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.42339096 |
16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33690755 |
17 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.29268835 |
18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.18221151 |
19 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 2.17498608 |
20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.09475315 |
21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.96570252 |
22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.93735831 |
23 | SPI1_23127762_ChIP-Seq_K562_Human | 1.88020672 |
24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.87441353 |
25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79180831 |
26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.76666420 |
27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.76455212 |
28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75459477 |
29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.75230196 |
30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.67039320 |
31 | MYB_26560356_Chip-Seq_TH2_Human | 1.66591532 |
32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.55556405 |
33 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.55029141 |
34 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.50523888 |
35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46366687 |
36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.39049913 |
37 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.36503326 |
38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35535840 |
39 | GATA3_26560356_Chip-Seq_TH2_Human | 1.33780803 |
40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33154971 |
41 | TP53_16413492_ChIP-PET_HCT116_Human | 1.30147414 |
42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28008418 |
43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27502681 |
44 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.27102424 |
45 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24655546 |
46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23435819 |
47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23381182 |
48 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23069682 |
49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23010204 |
50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20038261 |
51 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19847774 |
52 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.18530602 |
53 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17838688 |
54 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.17838688 |
55 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17059011 |
56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14177210 |
57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14047669 |
58 | MYB_26560356_Chip-Seq_TH1_Human | 1.11760019 |
59 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.11379377 |
60 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09712095 |
61 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.09664006 |
62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08760212 |
63 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.07590806 |
64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03921109 |
65 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.03559106 |
66 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.03464476 |
67 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.01816598 |
68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01625167 |
69 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01113392 |
70 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.95595198 |
71 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95396734 |
72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95383386 |
73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93775374 |
74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93209591 |
75 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93043826 |
76 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.92875788 |
77 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.92856562 |
78 | P300_19829295_ChIP-Seq_ESCs_Human | 0.92172282 |
79 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91965464 |
80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90804718 |
81 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90795385 |
82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89566627 |
83 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.89189468 |
84 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88700796 |
85 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88017488 |
86 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.87957051 |
87 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.87957051 |
88 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.87914744 |
89 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86030165 |
90 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.85709494 |
91 | STAT3_23295773_ChIP-Seq_U87_Human | 0.84264511 |
92 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84131734 |
93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.83784852 |
94 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83482733 |
95 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.82890307 |
96 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82097715 |
97 | TCF4_23295773_ChIP-Seq_U87_Human | 0.82055768 |
98 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.81669386 |
99 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.79005264 |
100 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.78547704 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000569_abnormal_digit_pigmentation | 5.28280522 |
2 | MP0000015_abnormal_ear_pigmentation | 4.47863750 |
3 | MP0001835_abnormal_antigen_presentation | 4.06561191 |
4 | MP0005174_abnormal_tail_pigmentation | 3.73902296 |
5 | MP0003172_abnormal_lysosome_physiology | 3.57937301 |
6 | MP0003191_abnormal_cellular_cholesterol | 3.44790197 |
7 | MP0002148_abnormal_hypersensitivity_rea | 3.08841304 |
8 | MP0003724_increased_susceptibility_to | 2.94621648 |
9 | MP0000372_irregular_coat_pigmentation | 2.92968892 |
10 | MP0006082_CNS_inflammation | 2.88333030 |
11 | MP0005171_absent_coat_pigmentation | 2.77030708 |
12 | MP0003806_abnormal_nucleotide_metabolis | 2.71183524 |
13 | MP0009785_altered_susceptibility_to | 2.67145735 |
14 | MP0005671_abnormal_response_to | 2.56223816 |
15 | MP0002095_abnormal_skin_pigmentation | 2.50705495 |
16 | MP0005000_abnormal_immune_tolerance | 2.47128732 |
17 | MP0004381_abnormal_hair_follicle | 2.44819942 |
18 | MP0002419_abnormal_innate_immunity | 2.42102620 |
19 | MP0003436_decreased_susceptibility_to | 2.25911342 |
20 | MP0001800_abnormal_humoral_immune | 2.22742653 |
21 | MP0005025_abnormal_response_to | 2.22549652 |
22 | MP0002452_abnormal_antigen_presenting | 2.05228126 |
23 | MP0005408_hypopigmentation | 2.04170099 |
24 | MP0000371_diluted_coat_color | 2.01774547 |
25 | MP0005075_abnormal_melanosome_morpholog | 2.01651667 |
26 | MP0002723_abnormal_immune_serum | 2.00177183 |
27 | MP0001790_abnormal_immune_system | 1.97760644 |
28 | MP0005387_immune_system_phenotype | 1.97760644 |
29 | MP0003183_abnormal_peptide_metabolism | 1.95427453 |
30 | MP0000685_abnormal_immune_system | 1.92627538 |
31 | MP0005464_abnormal_platelet_physiology | 1.81939884 |
32 | MP0002420_abnormal_adaptive_immunity | 1.79675906 |
33 | MP0001819_abnormal_immune_cell | 1.78256759 |
34 | MP0009840_abnormal_foam_cell | 1.69458326 |
35 | MP0002277_abnormal_respiratory_mucosa | 1.67943495 |
36 | MP0003136_yellow_coat_color | 1.63193760 |
37 | MP0003303_peritoneal_inflammation | 1.62795121 |
38 | MP0008260_abnormal_autophagy | 1.61178358 |
39 | MP0001845_abnormal_inflammatory_respons | 1.47747417 |
40 | MP0000604_amyloidosis | 1.43467052 |
41 | MP0009764_decreased_sensitivity_to | 1.39774490 |
42 | MP0005310_abnormal_salivary_gland | 1.35234347 |
43 | MP0006054_spinal_hemorrhage | 1.32788924 |
44 | MP0000716_abnormal_immune_system | 1.29951866 |
45 | MP0001533_abnormal_skeleton_physiology | 1.28301036 |
46 | MP0003186_abnormal_redox_activity | 1.27933449 |
47 | MP0003828_pulmonary_edema | 1.25697924 |
48 | MP0002877_abnormal_melanocyte_morpholog | 1.22751685 |
49 | MP0008469_abnormal_protein_level | 1.20674894 |
50 | MP0000343_altered_response_to | 1.17782677 |
51 | MP0001324_abnormal_eye_pigmentation | 1.17649300 |
52 | MP0000920_abnormal_myelination | 1.16248540 |
53 | MP0004883_abnormal_blood_vessel | 1.14849395 |
54 | MP0005164_abnormal_response_to | 1.11252572 |
55 | MP0003252_abnormal_bile_duct | 1.11091278 |
56 | MP0002398_abnormal_bone_marrow | 1.09525205 |
57 | MP0005058_abnormal_lysosome_morphology | 1.06607638 |
58 | MP0005409_darkened_coat_color | 1.06201755 |
59 | MP0001186_pigmentation_phenotype | 1.04439853 |
60 | MP0002075_abnormal_coat/hair_pigmentati | 1.04012086 |
61 | MP0000689_abnormal_spleen_morphology | 0.99064464 |
62 | MP0002405_respiratory_system_inflammati | 0.97702824 |
63 | MP0002429_abnormal_blood_cell | 0.92131869 |
64 | MP0005367_renal/urinary_system_phenotyp | 0.88687457 |
65 | MP0000516_abnormal_urinary_system | 0.88687457 |
66 | MP0009333_abnormal_splenocyte_physiolog | 0.88507373 |
67 | MP0004484_altered_response_of | 0.88130488 |
68 | MP0002166_altered_tumor_susceptibility | 0.86172236 |
69 | MP0004947_skin_inflammation | 0.84900928 |
70 | MP0003075_altered_response_to | 0.83978172 |
71 | MP0004742_abnormal_vestibular_system | 0.83785299 |
72 | MP0009763_increased_sensitivity_to | 0.81549273 |
73 | MP0005167_abnormal_blood-brain_barrier | 0.80077494 |
74 | MP0009765_abnormal_xenobiotic_induced | 0.79442594 |
75 | MP0002722_abnormal_immune_system | 0.77655267 |
76 | MP0003656_abnormal_erythrocyte_physiolo | 0.77162176 |
77 | MP0001986_abnormal_taste_sensitivity | 0.76945664 |
78 | MP0002998_abnormal_bone_remodeling | 0.73270246 |
79 | MP0002653_abnormal_ependyma_morphology | 0.70952659 |
80 | MP0004510_myositis | 0.70259069 |
81 | MP0001851_eye_inflammation | 0.69826446 |
82 | MP0002693_abnormal_pancreas_physiology | 0.68500640 |
83 | MP0002332_abnormal_exercise_endurance | 0.67162004 |
84 | MP0003763_abnormal_thymus_physiology | 0.66670867 |
85 | MP0003448_altered_tumor_morphology | 0.66391194 |
86 | MP0001663_abnormal_digestive_system | 0.65736326 |
87 | MP0005365_abnormal_bile_salt | 0.65599171 |
88 | MP0003632_abnormal_nervous_system | 0.63445978 |
89 | MP0005376_homeostasis/metabolism_phenot | 0.62556063 |
90 | MP0005248_abnormal_Harderian_gland | 0.62150116 |
91 | MP0010307_abnormal_tumor_latency | 0.60497220 |
92 | MP0002909_abnormal_adrenal_gland | 0.59748350 |
93 | MP0003690_abnormal_glial_cell | 0.58784526 |
94 | MP0008875_abnormal_xenobiotic_pharmacok | 0.56624363 |
95 | MP0010155_abnormal_intestine_physiology | 0.55987080 |
96 | MP0002177_abnormal_outer_ear | 0.55447993 |
97 | MP0009697_abnormal_copulation | 0.54898963 |
98 | MP0003091_abnormal_cell_migration | 0.53547436 |
99 | MP0005166_decreased_susceptibility_to | 0.50987574 |
100 | MP0002254_reproductive_system_inflammat | 0.49800335 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent bacterial skin infections (HP:0005406) | 5.97660829 |
2 | Recurrent abscess formation (HP:0002722) | 5.13919675 |
3 | Recurrent skin infections (HP:0001581) | 4.68051866 |
4 | Recurrent cutaneous fungal infections (HP:0011370) | 4.48764496 |
5 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.48764496 |
6 | Albinism (HP:0001022) | 4.38171415 |
7 | Systemic lupus erythematosus (HP:0002725) | 4.11421352 |
8 | Abnormality of macrophages (HP:0004311) | 3.88918495 |
9 | Glomerulonephritis (HP:0000099) | 3.65546169 |
10 | Gingivitis (HP:0000230) | 3.49890185 |
11 | Generalized hypopigmentation (HP:0007513) | 3.44257290 |
12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.42765254 |
13 | Periodontitis (HP:0000704) | 3.42350024 |
14 | Prostate neoplasm (HP:0100787) | 3.42016430 |
15 | Stomatitis (HP:0010280) | 3.41854488 |
16 | Recurrent fungal infections (HP:0002841) | 3.36120546 |
17 | Pustule (HP:0200039) | 3.31548743 |
18 | Ocular albinism (HP:0001107) | 3.26525571 |
19 | Thick nail (HP:0001805) | 3.19924703 |
20 | Cheilitis (HP:0100825) | 3.15785552 |
21 | Retrobulbar optic neuritis (HP:0100654) | 3.15776330 |
22 | Optic neuritis (HP:0100653) | 3.15776330 |
23 | Gastrointestinal infarctions (HP:0005244) | 3.15754724 |
24 | Abnormality of the prostate (HP:0008775) | 3.14354612 |
25 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.13505688 |
26 | Hemoptysis (HP:0002105) | 3.10666998 |
27 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.94179151 |
28 | Hypoplasia of the fovea (HP:0007750) | 2.94179151 |
29 | Orchitis (HP:0100796) | 2.90765038 |
30 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.87682211 |
31 | Eczematoid dermatitis (HP:0000976) | 2.84991198 |
32 | Esophageal neoplasm (HP:0100751) | 2.83651602 |
33 | Neoplasm of head and neck (HP:0012288) | 2.83651602 |
34 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.82361499 |
35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.82361499 |
36 | Abnormality of glycolipid metabolism (HP:0010969) | 2.82361499 |
37 | Iris hypopigmentation (HP:0007730) | 2.81747900 |
38 | Myositis (HP:0100614) | 2.72816899 |
39 | Pulmonary infiltrates (HP:0002113) | 2.65137362 |
40 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.62716008 |
41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.62716008 |
42 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.62716008 |
43 | Gingival bleeding (HP:0000225) | 2.60251051 |
44 | Premature loss of primary teeth (HP:0006323) | 2.60110854 |
45 | Urticaria (HP:0001025) | 2.58209127 |
46 | Mediastinal lymphadenopathy (HP:0100721) | 2.57584375 |
47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.54485384 |
48 | Mucopolysacchariduria (HP:0008155) | 2.49802991 |
49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.49802991 |
50 | Spinal muscular atrophy (HP:0007269) | 2.47835727 |
51 | Vasculitis (HP:0002633) | 2.44949122 |
52 | Dysostosis multiplex (HP:0000943) | 2.42203854 |
53 | Amyloidosis (HP:0011034) | 2.40725906 |
54 | Loss of speech (HP:0002371) | 2.39825918 |
55 | Chest pain (HP:0100749) | 2.34054375 |
56 | Epistaxis (HP:0000421) | 2.31481196 |
57 | Spontaneous hematomas (HP:0007420) | 2.29473917 |
58 | Meningitis (HP:0001287) | 2.29127280 |
59 | Prolonged bleeding time (HP:0003010) | 2.28209627 |
60 | Chronic obstructive pulmonary disease (HP:0006510) | 2.26398687 |
61 | Obstructive lung disease (HP:0006536) | 2.26398687 |
62 | Abnormality of T cell number (HP:0011839) | 2.23651591 |
63 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.23241157 |
64 | Abnormal platelet volume (HP:0011876) | 2.22292812 |
65 | Severe visual impairment (HP:0001141) | 2.19537478 |
66 | Congenital sensorineural hearing impairment (HP:0008527) | 2.17330081 |
67 | Abnormality of the fovea (HP:0000493) | 2.16384248 |
68 | T lymphocytopenia (HP:0005403) | 2.15589384 |
69 | Progressive cerebellar ataxia (HP:0002073) | 2.12170967 |
70 | Increased mean platelet volume (HP:0011877) | 2.11784019 |
71 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.11491107 |
72 | Subaortic stenosis (HP:0001682) | 2.11491107 |
73 | Increased cerebral lipofuscin (HP:0011813) | 2.06580840 |
74 | Type I transferrin isoform profile (HP:0003642) | 2.06461618 |
75 | Reduced antithrombin III activity (HP:0001976) | 2.05145463 |
76 | Osteolytic defects of the hand bones (HP:0009699) | 2.03921383 |
77 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.03921383 |
78 | Encephalitis (HP:0002383) | 2.03592980 |
79 | Hypoproteinemia (HP:0003075) | 2.02528559 |
80 | Keratoconjunctivitis sicca (HP:0001097) | 2.00692371 |
81 | Complement deficiency (HP:0004431) | 1.97420328 |
82 | Hip dysplasia (HP:0001385) | 1.97058342 |
83 | Abnormality of the endocardium (HP:0004306) | 1.96959508 |
84 | Postural instability (HP:0002172) | 1.96613643 |
85 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95799670 |
86 | Vacuolated lymphocytes (HP:0001922) | 1.94456870 |
87 | Recurrent viral infections (HP:0004429) | 1.94118123 |
88 | Impaired platelet aggregation (HP:0003540) | 1.93297475 |
89 | Abnormal platelet function (HP:0011869) | 1.93297475 |
90 | Abnormality of the peritoneum (HP:0002585) | 1.92343702 |
91 | Arterial tortuosity (HP:0005116) | 1.91360929 |
92 | Cutaneous melanoma (HP:0012056) | 1.89940546 |
93 | Blue irides (HP:0000635) | 1.88011925 |
94 | Melanoma (HP:0002861) | 1.87082415 |
95 | Abnormality of male internal genitalia (HP:0000022) | 1.86201283 |
96 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.85882769 |
97 | Abnormality of the anterior horn cell (HP:0006802) | 1.85235763 |
98 | Degeneration of anterior horn cells (HP:0002398) | 1.85235763 |
99 | Gangrene (HP:0100758) | 1.84441177 |
100 | Keratoconjunctivitis (HP:0001096) | 1.83849630 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BLK | 8.63722254 |
2 | WNK3 | 3.23734969 |
3 | TYK2 | 2.96358946 |
4 | RIPK4 | 2.88624713 |
5 | PIK3CG | 2.63521176 |
6 | CSK | 2.62465431 |
7 | BMPR2 | 2.62410610 |
8 | PDK2 | 2.48906874 |
9 | FRK | 2.14327448 |
10 | JAK1 | 2.10641233 |
11 | TGFBR2 | 2.06872873 |
12 | SYK | 2.05103724 |
13 | MAP2K3 | 1.96891288 |
14 | PAK3 | 1.80530393 |
15 | MARK3 | 1.78248697 |
16 | MAP3K14 | 1.75480414 |
17 | TRPM7 | 1.63693704 |
18 | FES | 1.54224729 |
19 | IRAK4 | 1.54121139 |
20 | FER | 1.51853582 |
21 | FGR | 1.51047701 |
22 | LYN | 1.48638790 |
23 | KIT | 1.44125704 |
24 | MAP3K3 | 1.31872321 |
25 | TAOK3 | 1.29824203 |
26 | YES1 | 1.27962946 |
27 | TXK | 1.27959707 |
28 | CSF1R | 1.20306828 |
29 | JAK3 | 1.16433911 |
30 | CAMKK2 | 1.12952696 |
31 | ACVR1B | 1.12345805 |
32 | SGK2 | 1.10345893 |
33 | EIF2AK3 | 1.07643540 |
34 | KSR1 | 1.06669280 |
35 | STK38L | 1.06337514 |
36 | IKBKE | 1.05527225 |
37 | PTK2B | 1.03843688 |
38 | ZAP70 | 1.03288695 |
39 | MAP4K1 | 1.00977601 |
40 | MAPKAPK5 | 1.00169141 |
41 | CAMK1G | 0.98046441 |
42 | HCK | 0.97116321 |
43 | SGK3 | 0.96013435 |
44 | PDGFRB | 0.92568437 |
45 | TAF1 | 0.91108249 |
46 | BTK | 0.84380615 |
47 | CAMK1D | 0.84164377 |
48 | MKNK1 | 0.82008662 |
49 | IKBKB | 0.81401823 |
50 | MAP3K2 | 0.78646678 |
51 | LCK | 0.77279626 |
52 | TNK2 | 0.75091987 |
53 | MATK | 0.74979338 |
54 | EGFR | 0.72279674 |
55 | GRK6 | 0.69787177 |
56 | ITK | 0.68845627 |
57 | FYN | 0.66543205 |
58 | PRKCH | 0.65625027 |
59 | MAP2K1 | 0.64216585 |
60 | CAMK4 | 0.62198128 |
61 | TEC | 0.61681731 |
62 | WNK1 | 0.60459605 |
63 | ABL1 | 0.59902104 |
64 | JAK2 | 0.58162333 |
65 | STK4 | 0.53241081 |
66 | ERBB2 | 0.52205030 |
67 | FGFR1 | 0.51962395 |
68 | TESK2 | 0.51961635 |
69 | ADRBK2 | 0.51171893 |
70 | SGK223 | 0.51018006 |
71 | SGK494 | 0.51018006 |
72 | MAP3K7 | 0.50044912 |
73 | PLK2 | 0.49863152 |
74 | RPS6KA5 | 0.49743249 |
75 | IRAK1 | 0.47751448 |
76 | EPHB2 | 0.47699004 |
77 | PRKCQ | 0.47052076 |
78 | MAP3K4 | 0.44144410 |
79 | PDK1 | 0.41668206 |
80 | TBK1 | 0.39529746 |
81 | EIF2AK2 | 0.37407428 |
82 | STK11 | 0.36725732 |
83 | PRKAA2 | 0.36147232 |
84 | CHUK | 0.35452294 |
85 | MAPK12 | 0.34905295 |
86 | NEK6 | 0.34463890 |
87 | MAPK11 | 0.34105542 |
88 | AKT3 | 0.33133158 |
89 | STK38 | 0.28565604 |
90 | INSR | 0.27971115 |
91 | STK24 | 0.27969620 |
92 | PRKCI | 0.27350446 |
93 | ERBB3 | 0.26916359 |
94 | MAP3K1 | 0.26533846 |
95 | MAPK13 | 0.26497446 |
96 | IGF1R | 0.25469634 |
97 | PRKACB | 0.21995272 |
98 | MAP2K6 | 0.20683810 |
99 | PIM1 | 0.20516617 |
100 | GSK3A | 0.18989571 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.12584532 |
2 | Asthma_Homo sapiens_hsa05310 | 4.45518614 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 4.11568281 |
4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.88618674 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.76118682 |
6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.46336200 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.34058765 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 3.19419477 |
9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.51778509 |
10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.43474764 |
11 | Viral myocarditis_Homo sapiens_hsa05416 | 2.29822124 |
12 | Tuberculosis_Homo sapiens_hsa05152 | 2.24793888 |
13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.14218433 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.01895802 |
15 | Phagosome_Homo sapiens_hsa04145 | 2.01173246 |
16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94947024 |
17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.78385270 |
18 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.77949342 |
19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.74963243 |
20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.68590913 |
21 | Influenza A_Homo sapiens_hsa05164 | 1.65328059 |
22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55848674 |
23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.37051071 |
24 | Lysosome_Homo sapiens_hsa04142 | 1.35051525 |
25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35010920 |
26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34171334 |
27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33329150 |
28 | Measles_Homo sapiens_hsa05162 | 1.26313476 |
29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.26001819 |
30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22953096 |
31 | Malaria_Homo sapiens_hsa05144 | 1.16576195 |
32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.06686162 |
33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04985602 |
34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02910969 |
35 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.02903621 |
36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.01345453 |
37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01070567 |
38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.97438847 |
39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94634534 |
40 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.94104754 |
41 | Legionellosis_Homo sapiens_hsa05134 | 0.92626822 |
42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.85337394 |
43 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85085821 |
44 | Pertussis_Homo sapiens_hsa05133 | 0.81258755 |
45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80546420 |
46 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79591582 |
47 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.77775888 |
48 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74564188 |
49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73183162 |
50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70093340 |
51 | Platelet activation_Homo sapiens_hsa04611 | 0.67281282 |
52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64523365 |
53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59717543 |
54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59269588 |
55 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57911798 |
56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56596877 |
57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54690190 |
58 | Shigellosis_Homo sapiens_hsa05131 | 0.51898993 |
59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47821733 |
60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.47739631 |
61 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37765934 |
62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35678534 |
63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34793318 |
64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.33602825 |
65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33357410 |
66 | Hepatitis B_Homo sapiens_hsa05161 | 0.33150523 |
67 | Hepatitis C_Homo sapiens_hsa05160 | 0.31670245 |
68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30592256 |
69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25313721 |
70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23592816 |
71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19092363 |
72 | Salmonella infection_Homo sapiens_hsa05132 | 0.17167810 |
73 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.17148750 |
74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.16087276 |
75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15315834 |
76 | Apoptosis_Homo sapiens_hsa04210 | 0.14489217 |
77 | ABC transporters_Homo sapiens_hsa02010 | 0.14189502 |
78 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.13001708 |
79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.12956081 |
80 | Endocytosis_Homo sapiens_hsa04144 | 0.10645918 |
81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.10156302 |
82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.08572494 |
83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.07816110 |
84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.06950364 |
85 | Protein export_Homo sapiens_hsa03060 | 0.06672447 |
86 | Lysine degradation_Homo sapiens_hsa00310 | 0.05665308 |
87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04817062 |
88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.04482158 |
89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.04215618 |
90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.03762453 |
91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.01614942 |
92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.01161987 |
93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.00534286 |
94 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0264080 |
95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | -0.0242713 |
96 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | -0.0171903 |
97 | Insulin resistance_Homo sapiens_hsa04931 | -0.0156558 |
98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | -0.0129474 |
99 | VEGF signaling pathway_Homo sapiens_hsa04370 | -0.0129131 |
100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | -0.0102403 |